BDSX: Biodesix, Inc. Stock

by  •  • Comments Off on BDSX: Biodesix, Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 142.03
Enterprise Value ($M) 151.03
Book Value ($M) 4.58
Book Value / Share 0.04
Price / Book 31.01
NCAV ($M) -54.83
NCAV / Share -0.48
Price / NCAV -2.59

Profitability (mra)
Return on Invested Capital (ROIC) -0.79
Return on Assets (ROA) -0.65
Return on Equity (ROE) -11.46

Liquidity (mrq)
Quick Ratio 1.15
Current Ratio 1.19

Balance Sheet (mrq) ($M)
Current Assets 39.68
Assets 99.10
Liabilities 94.52
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 49.09
Operating Income -41.30
Net Income -52.15

Cash Flow Statement (mra) ($M)
Cash From Operations -22.87
Cash from Investing -23.06
Cash from Financing 29.13

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-09 13D/A Strobeck Matthew 4.98 11.84
04-09 13D/A Kennedy Lawrence T. Jr 18.70 1.02
04-09 13D/A Patience John 6.70 1.63
04-09 13D/A Schuler Jack W 27.20 0.82
02-07 13G/A Hirschman Orin 3.80 -38.79

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 17,047 8,673 196.55
2024-05-01 1,012 3,831 26.42
2024-04-30 8,529 12,753 66.88
2024-04-29 5,528 9,823 56.28

(click for more detail)

Similar Companies
CDNA – CareDx, Inc CNTG – Centogene N.V.


Financial data and stock pages provided by
Fintel.io